ABSTRACT
INTRODUCTION
Alternative splicing is an important regulatory mechanism, often controlled by developmental or tissue-specific factors. (Smith et al., 1989; Hodges and Bernstein, 1994) . Many alternatively spliced mRNAs may be expressed simultaneously in the same tissue, yielding an extensive set of proteins with distinct functions (Smith et al., 1989; Kochiwa et al., 2002) . In human, approximately 30-60% of genes undergo alternative splicing (Sutcliffe * To whom correspondence should be addressed. and Milner, 1988; Croft et al., 2000; Lander et al., 2001; Venter et al., 2001; Kochiwa et al., 2002) . In some cases, splice variants are associated with human diseases (Stallings-Mann et al., 1996; Liu et al., 1997; Siffert et al., 1998) .
Microarray technology has become a standard method for gene expression profiling. However, most microarray design and analysis is limited to detecting and measuring changes of expression for each gene. The current methods ignore, implicitly or explicitly, the presence of multiple splice variants in the same target mRNA pool. The reasons are many, but include the complexity of microarray designs to measure the multitude of splicing products and limitations of target labeling techniques. Being able to measure variant-level concentrations is important for accurate expression profiling, and consequently for obtaining a better understanding of the biological processes. Recently, several studies have applied microarray technology to this issue (Hu et al., 2001; Miki et al., 2001; Shoemaker et al., 2001; Clark et al., 2002; Kapranov et al., 2002; Yeakley et al., 2002) . Genomic tiling arrays and exon arrays can be used to identify co-regulated exons, which allows the inference of variant mixtures (Shoemaker et al., 2001; Kapranov et al., 2002) . Expression arrays with multiple probes have been retrospectively analyzed to identify exons that are differentially included or skipped in a tissue-specific manner (Hu et al., 2001) . RNA-mediated ligation combined with arrays presents a novel method for detecting exon-exon junction information of known splice variants (Yeakley et al., 2002) . Most recently splice junction spanning oligonucleotides representing nearly all yeast splicing events have been used to monitor the genome-wide effects of splicing factor mutations in yeast (Clark et al., 2002) , suggesting exon joining information can be accessed using oligonucleotide arrays. To date, there is no analysis that provides quantitative measure of different variants' expression levels.
Li and Wong adopted a model-based approach to estimate gene expression by fitting expression data at the probe level across multiple experiments (Li and Wong, 2001) . Their model applies a simple formula linking intensity to concentration using the fact that all probes from the same probe set hybridize to the same target. This approach can reasonably address probe specific behavior and detect and eliminate outlier probes to give better expression estimates.
Inspired by their method, we developed an algorithm to estimate splice variant expression level by incorporating gene structure information. The gene structure specifies the features of each variant, where features can be both exons and exon-exon junctions. Probes are tiled selectively along certain features. Thus the probe intensity reflects the total concentration of the feature to which the probe belongs. Since a combination of features defines a variant, probe intensity then reflects the total concentration of one or more transcripts. By capturing these relationships, we are able to deconvolute the relative abundance of each variant in a set of samples. Data from these probes is fit across multiple experiments with a squared error loss function used to minimize the differences between predicted and observed values. Parameters are estimated iteratively using a maximum likelihood estimation (MLE) framework. The algorithm outputs the relative concentration of each variant, as well as an affinity term associated with each probe. Its efficiency is demonstrated through experiments on spiked clones and endogenous tissue samples.
METHODS AND MATERIALS
A special splice variant chip was designed using 21 wellcharacterized genes. The chip design process includes sequence selection, gene selection and probe selection.
Sequence selection
All mRNA and cDNA sequences were mapped to the Golden Path Genomic sequences (April 2001 release) using psLayout (Kent and Haussler, 2001 ). Based on the alignments, we characterized genes and generated unique splice variants. Then gene features including exons, introns and junctions were extracted and loaded into a relational database.
Gene selection
21 genes were selected from the literature (including ACHE, APAF1, BCL2L1, BCLG, BRCA1, CALCA, CALCR, CASP2, CD44, DNMT3B, FGF1, IL15, ITGA3, ITGA6, MAPT, MYLK, PSEN1, THRA, TNNT2, TPM2 and WNT2B). These genes were selected because their alternative splicing has been well studied using standard techniques of RNA analysis. The regulation of these genes at the level of splicing plays an important role in biological processes such as cancer and muscle development. Sequence information of each gene is extracted from the sequence selection database described above. A splice variant chip is then designed based on the information of these 21 genes.
Probe selection
There are two main types of probes: exon probes and junction probes. Exon probes are selected using Affymetrix's expression probe selection software (Mei et al., 2003) . If two exons overlap, probes are selected from the overlapping regions and the unique regions. Junction probe tiling is position-constrained. We choose eight symmetrically positioned probes across junctions. The center position of these probes relative to the junction are −5,−3,−2,−1,+1,+2,+3,+5. Figure 1 summarizes the probe tiling strategy.
Clones
Three CD44 splice variants represented by IMAGE clone ID: 588908 (clone 1), 118372 (clone 2) and 3638681 (clone 3) were purchased from Invitrogen Inc. The simplified structures of these clones are shown in Figure 5B .
ALGORITHM

Probe models
Based on the Li and Wong reduced model (Li and Wong, 2001) , the relationship between probe intensity and target transcript concentration measured by probes and probe affinities can be expressed by the following formula: Here, PM and MM are probe intensities for perfect match and mismatch respectively, the target transcript concentration measured by a probe is denoted by x, α denotes the probe affinity term and we use ε to denote the error term where ε ∼ N (0, σ 2 ).
Since a transcript is usually represented by multiple probes and has different concentrations in different experiments, the above formula is generalized to:
where i is the index for probes and j is the index for experiments. We extend Equation (2) to the problem of measuring the concentrations of several splice variants.
Models in the context of gene structure and application to alternative splicing A transcript may be uniquely identified by a set of features, each of which may be represented by a series of probe sequences. A gene feature can be either an exon, intron, partial exon, intron, or a junction (exonexon junction, exon-intron junction, intron-exon junction). Exon features can be partitioned further depending on whether the exon is a cassette exon or an exon overlapping with others. Intron features may be treated the same way. Probes can be mapped to the features that contain them, and in turn, the features can be mapped to the transcripts that contain them. We represent these relationships via matrices. Typically, a gene structure contains all known transcripts of each gene and the feature composition for each transcript, but it also can contain only a subset of features of interest. The relationship between features and transcripts can be represented by a q-by-t matrix G = (g lk ) containing binary values of 1 or 0, where g lk = 1 means feature l is present in transcript k, while g lk = 0 means this feature is absent. The total number of transcripts is t and q is the total number of features. The transcript concentrations of a given gene in all experiments are represented by a t-by-x matrix T = (t k j ), where t k j represents the concentration of transcript k in experiment j. Here x is the total number of experiments. Let C = (c l j ) be the q-by-x matrix defined by C = GT . It is easily seen that c l j is the concentration of feature l in experiment j.
The mapping of probes to features is represented in a similar way by a matrix F. Multiple probes can be chosen to represent each gene feature and some probes can be in more than one feature. Matrix F = ( f il ) is a p-by-q matrix with values 0 or 1, where p is the total number of probes, q is the total number of features, f il equals 1 if probe i belongs to feature l, and f il equals 0 otherwise. Let X = FC. Thus X = (x i j ) is a p-by-x matrix and x i j is the sum of the concentrations in experiment j of all the features to which probe i belongs. By the definition of C and F, x i j is the actual concentration of all the target transcripts in experiment j interrogated by probe i.
We develop an equation analogous to (1) that relates the matrix X of actual concentrations to the matrix Y of observed probe intensities. Let A = (a ii ) be a p-by-p diagonal matrix where a ii represents the probe affinity term. The predicted probe intensities can then be expressed as AX = AF GT . The observed probe intensities are given by a p-by-x matrix Y = (y i j ), where y i j is the intensity of probe i for experiment j. The observed probe intensities will equal the predicted probe intensities plus experimental error denoted by E = (ε i j ) as shown in Equation (2). Thus the matrix version of Equation (2) is Y = AX + E = AF GT + E. To illustrate this formulation, Figure 2 shows all matrices of a simple gene with 2 transcripts, 3 features and 2 probes per feature.
Model fitting and minimization
We want to minimize the differences between the predicted and observed intensities for all probes using a maximum likelihood framework. Since we are assuming Gaussian noise, this leads to a standard regression framework, so we use the squared error loss function.
The squared difference between predicted and observed intensity values for all probes of each gene can be written as function f (A, T ) = (||Y − AF GT || 2 ) 2 . We want to minimize f over the unknowns A and T .
Some constraints or penalty terms are needed in order to solve this minimization problem because it is underconstrained as stated. Thus the following constraints are added:
Where z in equation (3) is the total number of probes used in the constraint. Equations (4) and (5) reflect the fact that concentration and affinity terms must be non-negative.
Alternatively to (3), we can add γ (||A|| 2 ) 2 to f , where γ is a small positive constant.
Solving the minimization problem with constraints (3)-(5) corresponds to maximum likelihood estimation (MLE). This can be approached by alternately fixing A and solving for T , then fixing T and solving for A until convergence. Each step in this procedure is a linear least squares minimization with linear constraints. The final values of T and A yield the relative concentration of each transcript variant and the relative affinity term of each probe.
RESULTS
We validated our model using two approaches. First, we applied the model to a set of controlled experiments with spiked clones, and compared predicted concentrations to actual concentrations. Second, we applied it to the analysis of endogenous tissue samples, confirming the results with the TaqMan PCR assay. All experiments used a customdesigned Affymetrix microarray for detecting the 21 welldocumented human genes that exhibit splice variation.
Two-variant spike experiments
We tested the accuracy and sensitivity of the algorithm with dilution experiments (using yeast complex background) using target preparations derived from pairs of cDNA clones representing two splice variants from the same gene. In one set, we mixed target derived from two CD44 variants (clone 1 and clone 2) with differing concentrations: the first variant ranged from 0 to 64 pM and the second variant ranged from 64 pM to 0 pM with the total concentration held constant at 64 pM. By diluting the whole set 4 and 16 times, we obtained further results for titration experiments with total concentrations of 16 pM and 4 pM respectively. The variant concentrations as well as the results from the algorithm are detailed in Figure 3 .
In all three sets of experiments, the predicted concentration of each variant (indicated by bars in Fig. 3 ) is similar to the actual concentration (indicated by lines in Fig. 3) . Furthermore, the individual concentrations are consistent between different experiments. For instance, the 8 pM concentration of variant 2 in the 64 pM set of experiments is comparable to the 8 pM sample in the 16 pM set, and the predictions for 4 pM concentration are similar in all three sets of experiments. Each ratio of the two variants was tested three times: at the 64 pM, 16 pM, and 4 pM total concentration levels. In each case, the predicted concentration mirrored the actual concentrations. Thus, we are able to compare the relative abundance of the targets in different samples. The results indicate that the algorithm is very sensitive, as it can detect concentrations as low as 0.5 pM.
This two-variant spike experiment was also done with different sets of genes, including ACHE, TPM2, MYLK and MAPT. Similar results were obtained for each of the different variant pairs (data not shown). Figure 4 shows the correlation of the predicted concentration with the actual concentrations of the two variants of CD44 and TPM2. The R 2 scores between the predicted concentrations and the actual concentrations for these tested pairs are greater than 0.94.
Three-variant spike experiments
In order to test a more general case, a third CD44 variant (clone 3) was added. The experiment was designed to test all possible combinations of clones at 0 and 4 pM under simple background. In general, the predicted concentrations are consistent with the actual concentration of each variant as shown in Figure 5A .
TPM2 tissue experiments
Further validation was performed on tissue samples, studying the gene TPM2. Beta-tropomyosin gene contains in its central portion two mutually exclusive exons (A and B). Variants containing exon A (TPM2-A) are mainly present in skeletal muscle, while variants containing exon B (TPM2-B) are present in non-muscle and smooth muscle tissues (MacLeod et al., 1985; Helfman et al., 1986; Widada et al., 1988; Clouet d'Orval et al., 1991; Lees-Miller and Helfman, 1991; Novy et al., 1993; Beisel and Kennedy, 1994; Pittenger et al., 1995; Gallego et al., 1996) . Figure 6A shows the predicted relative concentrations of TPM2-A and TPM2-B of 7 human tissues. Based on the prediction, TPM2-A is observed in adult and fetal skeletal muscle, as well as esophagus and fetal heart. TPM2-B is not observed in skeletal muscle, as expected, but is observed in esophagus, stomach, uterus, and fetal umbilical cord (Helfman et al., 1986) . The result is consistent with Taqman quantitative PCR validation for selected tissues (Fig. 6B) .
DISCUSSION
This work demonstrates that our gene structure-based approach can be used to estimate the relative abundance of splice variants. The algorithm generates the relative concentration of each variant and an affinity term associated with each probe. The predicted concentrations can be used to compare the expression level of multiple variants of the same gene in a sample as well as expression changes of the same variant across multiple samples.
Generic model
As described above, the reduced probe model assumes that mismatch probes account for all non-specific hybridizations. However this is often not true. A more generic model includes a background term for each probe. The probe model in formula (1) is then expressed as:
If we let the column vector b = (b i ) represent probespecific background terms, 1 = (1 j ) be the row vector of 1s, and B = b 1 be the outer product of these, then as above we can generalize (6) to
Since B is treated as a property of probe, in the minimization process we solve for B at the same time we solve for the affinity term A.
Limitations of the algorithm
Degeneracy occurs when there is no unique solution for each of the variants. As mentioned above, the G matrix represents the relationship between transcripts and features of interest. It is obvious, for example, if the number of features is less than the number of transcripts, there is no unique solution. A simple alternative is to combine and solve for the concentration of several transcripts altogether. Other complications such as the 'ill-conditioned' situation, a classical matrix computation problem, can make computation quite difficult. Many techniques such as orthogonal transformation can be applied to help solve the problem.
This algorithm is intended for splice variant typing, not discovery. A limitation exists when the input gene structure is incorrect, which can happen when there are unknown transcripts present in the test samples. The robustness of the method is a topic of ongoing research.
Three-variant spike experiments
Even though the predicted concentrations are consistent with the variants' actual concentrations, some inconsistencies are evident (Fig. 5A) . First, the concentration of variant 1 appears to be lower than that of variant 2 and 3 (experiments 2, 3 and 5). Given careful examination and gel analysis, it appears that the actual spiked concentrations of variants 2 and 3 are higher than 4 pM due to a consistent error in estimation of the molar amount of spiked transcripts. This error is probably caused by the greater efficiency of full length transcript synthesis for the shorter variant transcripts in our in vitro transcription reactions.
Second, both experiment 5 (0,4,0) and 6 (0,4,4) show non-zero concentrations of variant 1. We hypothesize that it is related to a splice variant specific junction effect: cross hybridization from partially-overlapping junctions, specifically those beginning or ending at the same exon. In this example, the junction probes of variant 1 partially overlap with those of variant 2 and 3 (Fig. 5B) . We call these partially-overlapping junctions competitive junctions. Future work will include development of a model for this junction-specific effect.
In conclusion, we have developed an efficient algorithm for estimating the relative concentrations of splice variants. This algorithm can potentially help in obtaining a more accurate interpretation of microarray data and thus a better understanding of biological functions.
